Pharma and Life Sciences Validated Workflows with AI Agents: Why RPA Breaks and Computer Use Agents Last
Pharma and life sciences teams are buried in manual approvals, document checks, and lab data entry. When those processes sit on top of third‑party systems, vendor portals, and CRMs, simple automation is hard. Traditional RPA needs exact UI selectors. A small layout change breaks the bot. A generic SOP can’t be executed without a human. The result is a backlog of broken bots and processes that only people can run.
Why RPA breaks here
RPA tools like UiPath, Automation Anywhere, and Power Automate rely on stable selectors, XPath, and object IDs. In pharma, those elements change frequently. Regulatory updates, new vendor portals, and internal system refreshes all break the bots. When a bot hits an error, it halts and waits for a human. That “halt‑on‑exception” pattern creates a bottleneck. For many teams, the cost of maintaining RPA is a hidden and growing percentage of the total automation budget. Research shows that a significant portion of RPA maintenance time goes into fixing selector breaks and unexpected UI states. The process that should save time ends up consuming more time.
What changes with computer use agents
- ●Agents see the screen like a person: they locate buttons and fields visually, not through brittle selectors.
- ●When the UI changes, they adapt rather than fail. No rebuild on every update.
- ●They recover from exceptions and unexpected states instead of halting.
- ●They can follow SOPs written in plain English, with no separate bot flowcharts.
- ●They work across any application, including legacy systems, Citrix, and virtualized desktops where RPA struggles.
The one line a VP of automation should remember: RPA survives stable, high‑volume tasks; computer use agents survive the changing UIs and exception‑heavy processes that RPA cannot.
How to move without the risk
Moving to computer use agents does not require abandoning RPA overnight. The pragmatic path is to treat agents as an addition, not a replacement. Start by identifying one process that is high‑pain and high‑visibility. It should be something with frequent UI changes, many exceptions, or a written SOP that people struggle to follow. Run a pilot with an AI agent that can see the screen and execute the steps. Measure how much time the agent saves versus the manual effort. Once the pilot demonstrates value, expand to similar processes. Over time, you can gradually shift workloads from RPA to agents where agents clearly outperform bots. RPA still has a place for high‑volume, deterministic backend tasks. The goal is to reduce the overall maintenance burden and increase the number of processes that can run reliably without human intervention.
Why computer use agents fit pharma workflows
Pharma workflows often involve multiple systems, strict documentation, and frequent audits. A computer use agent can read a SOP, navigate to the correct forms, fill in data, and capture results. It can handle document uploads, approval routing, and compliance checks. Because agents see the screen, they can adapt when a label changes or a field moves. They can also handle mixed environments, some systems are modern web apps, others are legacy terminals. Agents can work across them without custom integrations. This flexibility means you can automate processes that were previously considered “too complex” for RPA alone.
You can stop rebuilding bots every time a vendor updates their portal. You can start following SOPs directly with AI agents that see and adapt. To see how computer use agents can build durable automation for your pharma and life sciences workflows, book a demo with the Coasty team at https://cal.com/coasty/15min.